Lysosomal Therapeutics Investors
Lysosomal Therapeutics deliver cures for neurodegenerative diseases.
Technology:
Others
Industry:
Biotechnology, Health Care, Therapeutics
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2011
Employees Number:
1-10
Funding Status:
M&A
Number Of Exits:
2
Estimated Revenue:
$1M to $10M
Register and Claim Ownership